Mark Cuban Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.

Colorado acting Gov. Dianne Primavera signed legislation May 30 that bans using the body mass index when determining care for eating disorder patients and prohibits the sale of diet pills to people under 18. 

Johnson & Johnson-owned Janssen Pharmaceuticals has submitted an application to the FDA for approval of what would be the first tablet therapy for patients with pulmonary arterial hypertension. 

Drug prices are rising faster than inflation, according to a new report from the American Hospital Association.

The FDA proposed a new, one-page medication guide outline for prescription drugs and biologics to ensure a "consistent and easy-to-understand format" for patients, the agency said May 30. 

There's a case for EDs to dispense medications as the U.S. tracks low medication adherence after emergency visits, according to an American Academy of Pediatrics study published May 30. 

Health experts are hoping the next altered COVID-19 vaccine will return to being monovalent but focus solely on XBB.1, The Atlantic reported May 26. 

An ongoing shortage of cancer drug cisplatin just got longer. 

Patient safety is often viewed from a lens inside medical center and hospital walls, but the leadership of pharmacists and decisions made along the medical supply chain also play a role, Londa Ritchey, the quality director at PharmaLex wrote in a May 25 article for PharmaPhorum.

The ongoing amoxicillin shortage is projected to continue into June, according to a May 22 update from the American Society of Health-System Pharmacists.

PTC Therapeutics, a drug development company based in South Plainfield, N.J., said it will lay off 94 employees at its corporate office by Aug. 21, according to a notice filed in the state. 

The FDA granted Pfizer's popular COVID-19 antiviral treatment, Paxlovid, full approval on May 25.

Some hospitals are scraping vials to offer enough cancer drugs for their patients as the U.S. faces about two dozen chemotherapy shortages.

Billionaire and Shark Tank investor Mark Cuban will soon start selling five Pfizer brand-name drugs through his pharmaceutical company, Mark Cuban Cost Plus Drug Co. 

Following the Federal Trade Commission's expanded probe into pharmacy benefit managers and their group purchasing organizations, Drug Channels listed five possible reasons why PBMs create GPOs.

Mark Cuban Cost Plus Drug Co. lowered prices for 18 drugs May 23, according to a company tweet. 

There is not enough supply for usual ordering of ribavirin inhalation solutions, a drug for severe pediatric pneumonia cases caused by respiratory syncytial virus, according to a May 23 post from the American Society of Health-System Pharmacists. 

On May 23, the FDA approved a new drug intended to treat hospital-acquired pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus, a critical bacterial pathogen. 

The American Hospital Association and American Society of Health-System Pharmacists, along with four other groups, recently sent a letter to the House Energy and Commerce Committee's Health Subcommittee opposing two bill amendments that would affect 340B hospitals and stakeholders.

Moderna has purchased a new biomanufacturing facility in Marlborough, Mass., which will be designated for mRNA manufacturing. It is anticipated to open in September 2024, according to an April 28 report from the Worcester Business Journal.